somatostatin receptor imaging

You have access
⁶⁴Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Prospective, Head-to-Head Comparison of Imaging at 1 Hour and 3 Hours After Injection
Mathias Loft, Esben A. Carlsen, Camilla B. Johnbeck, Helle H. Johannesen, Tina Binderup, Andreas Pfeifer, Jann Mortensen, Peter Oturai, Annika Loft, Anne K. Berthelsen, Seppo W. Langer, Ulrich Knigge and Andreas Kjaer

Journal of Nuclear Medicine January 1, 2021, 62 (1) 73-80; DOI: https://doi.org/10.2967/jnumed.120.244509
You have access
A Prospective Observational Study to Evaluate the Effects of Long-Acting Somatostatin Analogs on ⁶⁸Ga-DOTATATE Uptake in Patients with Neuroendocrine Tumors
Anni Gålne, Helen Almquist, Martin Almquist, Cecilia Hindorf, Tomas Ohlsson, Erik Nordenström, Anna Sundlöv and Elin Trägårdh

Journal of Nuclear Medicine December 1, 2019, 60 (12) 1717-1723; DOI: https://doi.org/10.2967/jnumed.119.226332
You have access
Evaluating the Role of Theranostics in Grade 3 Neuroendocrine Neoplasms
Najeff Waseem, Carina Mari Aparici and Pamela L. Kunz

Journal of Nuclear Medicine July 1, 2019, 60 (7) 882-891; DOI: https://doi.org/10.2967/jnumed.118.217851
You have access
Long-Acting Somatostatin Analog Therapy Differentially Alters ⁶⁸Ga-DOTATATE Uptake in Normal Tissues Compared with Primary Tumors and Metastatic Lesions
Narjess Ayati, Sze Ting Lee, Rasoul Zakavi, Kunthi Pathmaraj, Louai Al-Qatawna, Aurora Poon and Andrew M. Scott

Journal of Nuclear Medicine February 1, 2018, 59 (2) 223-227; DOI: https://doi.org/10.2967/jnumed.117.192203
You have access
Head-to-Head Comparison of ⁶⁴Cu-DOTATATE and ⁶⁸Ga-DOTATOC PET/CT: A Prospective Study of 59 Patients with Neuroendocrine Tumors
Camilla B. Johnbeck, Ulrich Knigge, Annika Loft, Anne K. Berthelsen, Jann Mortensen, Peter Oturai, Seppo W. Langer, Dennis R. Elema and Andreas Kjaer

Journal of Nuclear Medicine March 1, 2017, 58 (3) 451-457; DOI: https://doi.org/10.2967/jnumed.116.180430
You have access
The Impact of ⁶⁸Ga-DOTATATE PET/CT Imaging on Management of Patients with Neuroendocrine Tumors: Experience from a National Referral Center in the United Kingdom
Evangelia Skoura, Sofia Michopoulou, Mullan Mohmaduvesh, Emmanouil Panagiotidis, Mohammed Al Harbi, Christos Toumpanakis, Omar Almukhailed, Irfan Kayani, Rizwan Syed, Shaunak Navalkissoor, Peter J. Ell, Martyn E. Caplin and Jamshed Bomanji

Journal of Nuclear Medicine January 1, 2016, 57 (1) 34-40; DOI: https://doi.org/10.2967/jnumed.115.166017
You have access
In Vivo Evaluation of ¹⁸F-SiFAlin–Modified TATE: A Potential Challenge for ⁶⁸Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET
Sabrina Niedermoser, Joshua Chin, Carmen Wängler, Alexey Kostikov, Vadim Bernard-Gauthier, Nils Vogler, Jean-Paul Soucy, Alexander J. McEwan, Ralf Schirrmacher and Björn Wängler

Journal of Nuclear Medicine July 1, 2015, 56 (7) 1100-1105; DOI: https://doi.org/10.2967/jnumed.114.149583
You have access
⁶⁴Cu-DOTATATE PET for Neuroendocrine Tumors: A Prospective Head-to-Head Comparison with ¹¹¹In-DTPA-Octreotide in 112 Patients
Andreas Pfeifer, Ulrich Knigge, Tina Binderup, Jann Mortensen, Peter Oturai, Annika Loft, Anne Kiil Berthelsen, Seppo W. Langer, Palle Rasmussen, Dennis Elema, Eric von Benzon, Liselotte Højgaard and Andreas Kjaer

Journal of Nuclear Medicine June 1, 2015, 56 (6) 847-854; DOI: https://doi.org/10.2967/jnumed.115.156539

Main menu

User menu

Search

somatostatin receptor imaging